These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32513535)
21. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children. Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347 [TBL] [Abstract][Full Text] [Related]
22. Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. Liu S; Han Z; Trivett AL; Lin H; Hannifin S; Yang D; Oppenheim JJ Cancer Immunol Immunother; 2019 Jul; 68(7):1059-1071. PubMed ID: 30972427 [TBL] [Abstract][Full Text] [Related]
23. Protective effects of pidotimod against experimental bacterial infections in mice. Coppi G; Falcone A; Manzardo S Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334 [TBL] [Abstract][Full Text] [Related]
24. Pidotimod: the past and the present. Zuccotti GV; Mameli C Ital J Pediatr; 2013 Dec; 39():75. PubMed ID: 24314100 [TBL] [Abstract][Full Text] [Related]
25. In vivo antiviral effects of pidotimod. Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337 [TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of pidotimod in combination with bacterial lysates in the treatment of the pfapa (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome]. Buongiorno A; Pierossi N Minerva Pediatr; 2015 Jun; 67(3):219-26. PubMed ID: 25941128 [TBL] [Abstract][Full Text] [Related]
27. The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD). Hu X; Zhang W; Wang L; Wan N; Wang B; Li W; Hua H; Hu X; Shan F Hum Vaccin Immunother; 2012 Sep; 8(9):1250-8. PubMed ID: 22863756 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study. Namazova-Baranova LS; Alekseeva AA; Kharit SM; Kozhevnikova TN; Taranushenko TE; Tuzankina IA; Scarci F Int J Immunopathol Pharmacol; 2014; 27(3):413-9. PubMed ID: 25280032 [TBL] [Abstract][Full Text] [Related]
29. Preventive effect of pidotimod on reactivated toxoplasmosis in mice. Huo XX; Wang L; Chen ZW; Chen H; Xu XC; Zhang AM; Song XR; Luo QL; Xu YH; Fu Y; Wang H; Du J; Cai YH; Lun ZR; Lu FL; Wang Y; Shen JL Parasitol Res; 2013 Aug; 112(8):3041-51. PubMed ID: 23774843 [TBL] [Abstract][Full Text] [Related]
30. Ex vivo evaluation of Pidotimod effect on immune response. Pugliese A; Marinelli L; Forno B; Pollono AM; Uslenghi C; Girardello R Pharmacol Res; 1992 Sep; 26 Suppl 2():178-9. PubMed ID: 1409298 [No Abstract] [Full Text] [Related]
31. Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod. di Marco R; Condorelli F; Girardello R; Uslenghi C; Chisari G; di Mauro M; Speciale AM; Meroni PL; Nicoletti F Scand J Infect Dis; 1992; 24(6):821-3. PubMed ID: 1287821 [TBL] [Abstract][Full Text] [Related]
32. [Astragalus polysaccharides combined with cisplatin decreases the serum levels of CD44 and collagen type IV and hyaluronic acid in mice bearing Lewis lung cancer]. Ming H; Chen Y; Zhang F; Wang Q; Dong X; Gu J; Li Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):909-13. PubMed ID: 26146060 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity of Lewis lung carcinoma to cisplatin undergoes considerable variations during growth and metastasizing. Solyanik GI; Garmanchuk LV; Pyaskovskaya ON; Yakshibaeva YR; Gorbik GV Bull Exp Biol Med; 2004 Sep; 138(3):295-7. PubMed ID: 15665927 [TBL] [Abstract][Full Text] [Related]
34. The in vitro effect of Pidotimod on some immune functions in cancer patients. Di Renzo M; Pasqui AL; Bruni F; Saletti M; Bova G; Chiarion C; Girardello R; Ferrì P; Auteri A Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):37-51. PubMed ID: 9049658 [TBL] [Abstract][Full Text] [Related]
35. Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study. Auteri A; Pasqui AL; Bruni F; Saletti M; Di Renzo M; Bova G Pharmacol Res; 1992 Sep; 26 Suppl 2():196-7. PubMed ID: 1409308 [No Abstract] [Full Text] [Related]
36. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood. Passali D; Calearo C; Conticello S Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354 [TBL] [Abstract][Full Text] [Related]
37. The concurrent treatment of Scutellaria baicalensis Georgi enhances the therapeutic efficacy of cisplatin but also attenuates chemotherapy-induced cachexia and acute kidney injury. Huang TH; Wu TH; Guo YH; Li TL; Chan YL; Wu CJ J Ethnopharmacol; 2019 Oct; 243():112075. PubMed ID: 31291609 [TBL] [Abstract][Full Text] [Related]
38. Effects of pidotimod soluble powder and immune enhancement of Newcastle disease vaccine in chickens. Qu S; Dai C; Qiu M; Zhang R; Wang C; Cui L; Hao Z Immunol Lett; 2017 Jul; 187():14-18. PubMed ID: 28487096 [TBL] [Abstract][Full Text] [Related]